VEGFA and age-related macular degeneration: Ricci et al. presented that the usage of Ranibizumab—a completely humanized monoclonal antibody fragment that attaches itself to several VEGF-A isoforms, effectively prevents the formation of new vessels and modifies the course of AMD [195].